We utilize a systematic process which prioritizes a set of industries and themes to proactively pursue.
Investment Date:Sep 2018
Current / Exited:Current
Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.